2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
This article has been corrected.
VIEW CORRECTIONAbstract
BACKGROUND:
The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, and obesity) and health factors (cholesterol, blood pressure, glucose control, and metabolic syndrome) that contribute to cardiovascular health. The AHA Heart Disease and Stroke Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, brain health, complications of pregnancy, kidney disease, congenital heart disease, rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary heart disease, cardiomyopathy, heart failure, valvular disease, venous thromboembolism, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs).
METHODS:
The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing. The 2024 AHA Statistical Update is the product of a full year’s worth of effort in 2023 by dedicated volunteer clinicians and scientists, committed government professionals, and AHA staff members. The AHA strives to further understand and help heal health problems inflicted by structural racism, a public health crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives. This year’s edition includes additional global data, as well as data on the monitoring and benefits of cardiovascular health in the population, with an enhanced focus on health equity across several key domains.
RESULTS:
Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics.
CONCLUSIONS:
The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.
Supplemental Material
File (europe and central asia cvd statistics supplement.pdf)
- Download
- 758.37 KB
File (global cvd statistics supplement.pdf)
- Download
- 1.22 MB
File (high-income countries cvd statistics supplement.pdf)
- Download
- 911.87 KB
File (latin america and caribbean cvd statistics supplement.pdf)
- Download
- 443.91 KB
File (north africa and middle east cvd statistics supplement.pdf)
- Download
- 663.51 KB
File (south asia cvd statistics supplement.pdf)
- Download
- 500.76 KB
File (southeast and east asia and oceania cvd statistics supplement.pdf)
- Download
- 590.95 KB
File (sub-saharan africa cvd statistics supplement.pdf)
- Download
- 609.21 KB
Information & Authors
Information
Published In
Copyright
© 2024 American Heart Association, Inc.
Versions
You are viewing the most recent version of this article.
History
Published online: 24 January 2024
Published in print: 20 February 2024
Keywords
Subjects
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Advance in the application of 4-dimensional flow MRI in atrial fibrillation, Magnetic Resonance Imaging, 115, (110254), (2025).https://doi.org/10.1016/j.mri.2024.110254
- Targeting cancer with novel tetra-1,2,3-triazole hybrids: Synthesis, biological evaluation, and molecular dynamics, Journal of Molecular Structure, 1321, (140245), (2025).https://doi.org/10.1016/j.molstruc.2024.140245
- Prediabetes and the Risk of Peripheral Artery Disease: A Meta-Analysis, Annals of Vascular Surgery, 110, (274-285), (2025).https://doi.org/10.1016/j.avsg.2024.06.045
- Comparative Efficacy and Safety of Novel Antiplatelets and Standard Therapy in Patients With Coronary Artery Disease, Cureus, (2024).https://doi.org/10.7759/cureus.71333
- Cardiovascular Disease in Women and the Role of Hormone Replacement Therapy, Cureus, (2024).https://doi.org/10.7759/cureus.69752
- Comparing the outcomes and costs of cardiac monitoring with implantable loop recorders and mobile cardiac outpatient telemetry following stroke using real-world evidence, Journal of Comparative Effectiveness Research, 13, 6, (2024).https://doi.org/10.57264/cer-2024-0008
- “East Asian Paradox” Revisited: Precision Medicine for Antithrombotic Strategies Tailored to Atherothrombotic Cardiovascular Risks, Journal of Cardiovascular Intervention, 3, 3, (119), (2024).https://doi.org/10.54912/jci.2024.0006
- Diabetic cardiomyopathy: Importance of direct evidence to support the roles of NOD-like receptor protein 3 inflammasome and pyroptosis, World Journal of Diabetes, 15, 8, (1659-1662), (2024).https://doi.org/10.4239/wjd.v15.i8.1659
- Cardiovascular Risk Awareness, Exercise Practices and Metabolic Outcomes among Patients with Diabetes Mellitus in Northern Nigeria: A Cross-sectional, Multicentre Study, Nigerian Postgraduate Medical Journal, 31, 2, (139-146), (2024).https://doi.org/10.4103/npmj.npmj_54_24
- Cardiorenal Benefit of Tirzepatide in Type 1 Diabetes: A Case Report, Journal of Diabetology, 15, 4, (447-451), (2024).https://doi.org/10.4103/jod.jod_97_24
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.